Leonard E Post
Director at CG Oncology, Inc. (CGON); Director at uniQure N.V. (QURE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $72.98 | $73K | -12.6% |
| Aug 18SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $74.54 | $75K | -14.4% |
| Jul 17SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $71.17 | $71K | -10.3% |
| Jun 25SEC | CGONCG Oncology, Inc. | Sell Plan | 5,000 | $70.00 | $350K | -8.8% |
| Jun 23SEC | CGONCG Oncology, Inc. | Sell Plan | 5,000 | $65.00 | $325K | -1.8% |
| Jun 12SEC | QUREuniQure N.V. | Sell | 1,99335,494 held (−5%) | $27.06 | $54K | -16.5% |
| Jun 5SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $54.50 | $54K | +17.1% |
| Nov 18SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $41.43 | $41K | +54.0% |
| Oct 15SEC | CGONCG Oncology, Inc. | Sell Plan | 1,000 | $43.25 | $43K | +47.6% |
| Oct 1SEC | CGONCG Oncology, Inc. | Sell Plan | 5,000 | $40.09 | $200K | +59.2% |
- Sell
Director Leonard E Post sold $73K of CGON at $72.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leonard E Post sold $75K of CGON at $74.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leonard E Post sold $71K of CGON at $71.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leonard E Post sold $350K of CGON at $70.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leonard E Post sold $325K of CGON at $65.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Leonard E Post sold $54K of CGON at $54.50 — pre-scheduled 10b5-1 plan sale.